DOUGLASS LILLY: Open Payments
NPI 1134192313 · DARLINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 13 payments from 11 companies in 2025. Trend: 2023 $275 · 2024 $169 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| Esperion Therapeutics, Inc. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| SCILEX PHARMACEUTICALS INC. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| Boston Scientific Corporation | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| CVRx, Inc. | 1 | $13 |
Products named: NEXLETOL, GVOKE HYPOPEN, ZTLido, SHINGRIX, Auvelity, Ozempic, WATCHMAN FLX, UBRELVY.
Industry payments across SC — which companies pay providers there.
